Abstract:Chronic rhinosinusitis (CRS) is a chronic inflammatory disease phenotypically classified by the absence (CRSsNP) or presence of nasal polyps (CRSwNP). The latter may also be associated with asthma and hypersensitivity towards non-steroidal anti-inflammatory drugs (NSAID) as a triad termed NSAID-exacerbated respiratory disease (N-ERD). The role of the microbiome in these different disease entities with regard to the underlying inflammatory process and disease burden is yet not fully understood. To address this question, we measured clinical parameters and collected nasal samples (nasal mucosal fluids, microbiome swabs from middle meatus and anterior naris) of patients suffering from CRSsNP (n=20), CRSwNP (n=20) or N-ERD (n=20) as well as from patients without CRS (=disease controls, n=20). Importantly, all subjects refrained from taking local or systemic corticosteroids or immunosuppressants for at least two weeks prior to sampling. The nasal microbiome was analyzed using 16S rRNA gene amplicon sequencing, and levels of 33 inflammatory cytokines were determined in nasal mucosal fluids using the MSD platform. Patients suffering from N-ERD and CRSwNP showed significantly worse smell perception and significantly higher levels of type 2 associated cytokines IL-5, IL-9, Eotaxin and CCL17. Across all 4 patient groups, Corynebacteria and Staphylococci showed the highest relative abundances. Although no significant difference in alpha and beta diversity was observed between the control and the CRS groups, pairwise testing revealed a higher relative abundance of Staphylococci in the middle meatus in N-ERD patients as compared to CRSwNP (p<0.001), CRSsNP (p<0.01) and disease controls (p<0.05) and of Lawsonella in patients suffering from CRSwNP in middle meatus and anterior naris in comparison to CRSsNP (p<0.0001 for both locations) and disease controls (p<0.01 and p<0.0001). Furthermore, we observed a positive correlation of Staphylococci with IL-5 (Pearson r=0.548) and a negative correlation for Corynebacteria and Eotaxin-3 (r=-0.540). Thus, in patients refraining from oral and nasal corticosteroid therapy for at least two weeks known to alter microbiome composition, we did not observe differences in microbiome alpha or beta diversity between various CRS entities and disease controls. However, our data suggest a close association between increased bacterial colonization with Staphylococci and decreased colonization by Corynebacteria as well as increased type 2 inflammation.

[Screening and Antibiotic Resistance Analysis of Nasal Colonized Bacteria in Patients with Chronic Rhinosinusitis].

[Secretion Analysis of Pathogenic Bacteria Culture in 115 Rural Chronic Nasal-Sinusitis Patients].

[Microbiology of Chronic Rhinosinusitis with Different Clinical Phenotypes].

The Microbiome of Chronic Rhinosinusitis: Culture, Molecular Diagnostics and Biofilm Detection

[Observation of bacterial biofilms in patients with chronic rhinosinusitis]

The intra-host evolutionary landscape and pathoadaptation of persistent Staphylococcus aureus in chronic rhinosinusitis

Antibiotic-Dependent Relationships Between the Nasal Microbiome and Secreted Proteome in Nasal Polyps

Bacteriological analysis of selected phenotypes of chronic rhinosinusitis with co-existing asthma, allergy and hypersensitivity to non-steroidal anti-inflammatory drugs

[Microbiological Study of Persistent Rhinosinusitis after Endoscopic Sinus Surgery].

Microbial Analysis in Chronic Rhinosinusitis Patients with Chronic Kidney Disease and End‐Stage Renal Disease

Reduced Glycolysis and Cytotoxicity in Staphylococcus aureus Isolates from Chronic Rhinosinusitis as Strategies for Host Adaptation

Sinus Microbiota in Patients With Eosinophilic and Non-Eosinophilic Chronic Rhinosinusitis With Nasal Polyps

Odontogenic and rhinogenic chronic sinusitis: a modern microbiological comparison

[Expert Consensus on the Diagnosis and Treatment of Chronic Sinusitis in Children].

[Relationship Between Bacterial Biofilm and Chronic Rhinosinusitis: a Systematic Review].

Age-Associated Changes of Nasal Bacterial Microbiome in Patients With Chronic Rhinosinusitis

Clinical Analysis of Chronic Invasive Fungal Rhinosinusitis

Chronic Rhinosinusitis—Microbiological Etiology, Potential Genetic Markers, and Diagnosis

Comparing the Nasal Bacterial Microbiome Diversity of Allergic Rhinitis, Chronic Rhinosinusitis and Control Subjects

Relationship between bacterial biofilm and clinical features of patients with chronic rhinosinusitis

The nasal microbiome in patients suffering from non-steroidal anti-inflammatory drugs-exacerbated respiratory disease in absence of corticosteroids